Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1650 of 3284 entries
View as:

Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study

Phase: N/A Priority: Normal
NCT ID: NCT00242801 Org: User:
Start: 07/31/03 End: 04/30/05 Due: 04/30/06

Epidemiological Study to Describe Non Small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Central Eastern Europe and Russia (Lung-EPICLIN)

Phase: N/A Priority: Normal
NCT ID: NCT01069835 Org: User:
Start: 02/28/10 End: 03/31/12 Due: 03/31/13

Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas

Phase: N/A Priority: Normal
NCT ID: NCT04924608 Org: User:
Start: 11/19/21 End: 03/17/25 Due: 03/17/26

Effect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).

Phase: N/A Priority: Normal
NCT ID: NCT00891124 Org: User:
Start: 05/31/09 End: 10/31/09 Due: 10/31/10

Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02369874 Org: User:
Start: 09/09/15 End: 11/13/20 Due: 11/13/21

Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo

Phase: N/A Priority: Normal
NCT ID: NCT01049360 Org: User:
Start: 12/31/09 End: 08/31/10 Due: 08/31/11

Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00690365 Org: User:
Start: 06/30/07 End: 04/30/08 Due: 04/30/09

A Study to Investigate the Sequencing Strategy of Pirtobrutinib After Disease Progression on First-line Acalabrutinib Treatment for Adult Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06839872 Org: User:
Start: 06/30/25 End: 07/29/30 Due: 07/29/31

Observational Study Protocol: LIVER-R

Phase: N/A Priority: Normal
NCT ID: NCT06252753 Org: User:
Start: 12/20/23 End: 12/30/30 Due: 12/30/31

An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT00683462 Org: User:
Start: 05/31/08 End: 07/31/09 Due: 07/31/10

Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT00750841 Org: User:
Start: 09/09/08 End: 12/31/25 Due: 12/31/26

Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.

Phase: N/A Priority: Normal
NCT ID: NCT01714726 Org: User:
Start: 02/01/13 End: 12/14/16 Due: 12/14/17

Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01144572 Org: User:
Start: 07/31/10 End: 10/31/13 Due: 10/31/14

A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib

Phase: N/A Priority: Normal
NCT ID: NCT04959266 Org: User:
Start: 06/28/21 End: 06/01/22 Due: 06/01/23

Prevalence of Emerging Treatment-induced Mutations in Metastatic ER-positive Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT06417801 Org: User:
Start: 06/17/24 End: 12/30/25 Due: 12/30/26

NIS Study Determining Prevalence of HER2-low in Metastatic Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06131424 Org: User:
Start: 04/23/24 End: 10/24/25 Due: 10/24/26

Faslodex Registry: Fulvestrant in Current Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT00735215 Org: User:
Start: 10/31/08 End: 12/31/09 Due: 12/31/10

Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC

Phase: N/A Priority: Normal
NCT ID: NCT04550260 Org: User:
Start: 10/19/20 End: 11/30/26 Due: 11/30/27

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06417814 Org: User:
Start: 10/04/24 End: 11/29/27 Due: 11/29/28

Study to Assess the Efficacy and Safety of Adjuvant Osimertinib in NSCLC With Uncommon EGFRm

Phase: N/A Priority: Normal
NCT ID: NCT05546866 Org: User:
Start: 02/09/23 End: 06/30/29 Due: 06/30/30

A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT05514132 Org: User:
Start: 09/23/22 End: 10/01/25 Due: 10/01/26

A Phase 1 Study of Acalabrutinib in Japanese Adult Patients With Advanced B-cell Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03198650 Org: User:
Start: 06/27/17 End: 12/31/25 Due: 12/31/26

A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases

Phase: N/A Priority: Normal
NCT ID: NCT06512883 Org: User:
Start: 04/17/25 End: 12/29/27 Due: 12/29/28

Study to Evaluate the Pharmacokinetics and Pharmacodynamics of AZD4604 Given Via the Turbuhaler® Device in Adults With Mild Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT06732882 Org: User:
Start: 02/27/25 End: 05/29/25 Due: 05/29/26

Change in Patient-repOrted Outcomes in COPD Patients Newly Initiated on TRIXEO AEROSPHERE in Real worlD

Phase: N/A Priority: Normal
NCT ID: NCT06368427 Org: User:
Start: 04/30/24 End: 09/30/25 Due: 09/30/26